Alpine Woods Capital Investors’s Kite Pharma, Inc. KITE Stock Holding History

Alpine Woods Capital Investors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-14,000	Closed	-$2.52M	–	479
2017 Q3	$2.52M	Hold	14,000	–	–	0.13%	165
2017 Q2	$1.45M	Sell	14,000 -1,000	-7%	-$81.6K	0.08%	201
2017 Q1	$1.18M	Hold	15,000	–	–	0.06%	234
2016 Q4	$673K	Hold	15,000	–	–	0.04%	280
2016 Q3	$838K	Hold	15,000	–	–	0.05%	263
2016 Q2	$750K	Hold	15,000	–	–	0.04%	270
2016 Q1	$689K	Hold	15,000	–	–	0.04%	273
2015 Q4	$924K	Hold	15,000	–	–	0.05%	247
2015 Q3	$835K	Buy	15,000 +5,000	+50%	+$315K	0.05%	273
2015 Q2	$610K	Hold	10,000	–	–	0.03%	291
2015 Q1	$577K	Hold	10,000	–	–	0.03%	309
2014 Q4	$577K	Buy	+10,000	New	+$421K	0.03%	308

Alpine Woods Capital Investors's KITE Position: Q4 2017 in Review

Alpine Woods Capital Investors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 14,000 shares — an estimated $2.52M sold.

Alpine Woods Capital Investors first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $2.52M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Alpine Woods Capital Investors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Alpine Woods Capital Investors sold 14,000 Kite Pharma, Inc. shares in Q4 2017, an estimated $2.52M.
Alpine Woods Capital Investors first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
Alpine Woods Capital Investors's Kite Pharma, Inc. position peaked at $2.52M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Alpine Woods Capital Investors's 13F filing for Q4 2017, filed 14 Feb 2018.